PF Equity Holdings 2 B.V.
SEC CIK 1883111 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ALLO | Allogene Therapeutics, Inc. | 10% | 0 | — | — | 1 | 2022-03-31 | 2022-03-31 |
Most active insiders at ALLO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Chang David D | Pres, CEO, Dir | — | $289.5K |
| 2 | Roberts Zachary | EVP of R, D | — | $104.2K |
| 3 | Douglas Earl Martin | SVP, GC | — | $103.3K |
| 4 | Parker Geoffrey M. | CFO | — | $88.5K |
| 5 | Beneski Benjamin Machinas | SVP, Chief Technical Off | — | $51.7K |
| 6 | Yoshiyama Annie | SVP, Fin | — | $29.3K |
| 7 | Kazam Joshua A | Dir | — | — |
PF Equity Holdings 2 B.V. made no open-market trades at ALLO in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-04 | 2022-03-31 | ALLO | Allogene Therapeutics, Inc. | PF Equity Holdings 2 B.V. | 10% | J - Other | $0.00 | -22.03M | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations